The Faces of APS

Saturday, April 21, 2007

APSFA is looking for volunteers

Hello,

The APS Foundation of America, Inc is a volunteer run organization. Without the people who run things behind the scenes, the APSFA could not provide to you the services that we do. If you are not familiar with the services we have to offer some of them are: a private online support forum which has hundreds of medical articles posted on a monthly basis, our extensive website that is constantly being checked for accuracy and updated to ensure our information is current, our informational brochures and other documents available for download, over a thousand of related links on our links pages, and a list of doctors in the USA who were recommend by other APS patients.

This time of year is extremely overwhelming for us because a lot of legal paperwork needs to be filed for our taxes and each state requires that we renew our applications so we have to focus on those. Unfortunately in doing so, we end up short in other areas that are important for continued success of the foundation.

We are currently looking for people who are willing to volunteer their time and talents to the APSFA to help us with things behind the scenes. Some of the areas in which we need assistance are as follows in no particular order


  • Grant Writing
  • Writing Newsletter Articles, including patient stories
  • Writing Press Releases
  • Writing Articles for public magazines such as Woman’s Day, Good House Keeping, etc.
  • Making podcasts and videos dealing with APS
  • Making Public Service Announcements for TV & Radio
  • Attending related seminars/conferences
  • Attending local Health Fairs
  • Contacting Hospitals & Related Agencies
  • Fundraising


If you are interested in volunteering to work with the APSFA in any of these areas or have any other suggestions, please email us at apsfa@apsfa.org and let us know. If you are a forum member, please also let us know your username. We will be setting up a special private area on the forum for the volunteers to share ideas and chat with each other.

Thank you for your time and continued support.


APS Foundation of America Staff
Tina, Heidi & Todd

APS Foundation of America, Inc

Thursday, April 12, 2007

CoaguChekXS Strip Insert

CoaguChekXS Strip Insert


Literature clearly states that this machine has problems with APS patient and patients with the Lupus Anticoagulant. This is for the CoaguChek, CoaguChekS and CoaguChekXS. Please call technical support at 800-428-4674 for more information. Those using this machine should be getting vein draw comparisons at least every 6-8 weeks.

http://www.apsfa.org/docs/XS%20Strip%20Package%20Insert.pdf

Tuesday, March 27, 2007

Michigan Seminar Summary, Notes and Pictures (Posted by Heidi)

"Breaking the Barriers: Blood Clots - Now What?"


This is my post on how the seminar went. it will probably be long, so please bear with me.

First let me say that if you have an opportunity to attend something like this, PLEASE try to make it there!! It was very good, informative and really a chance to get to ask some questions you may have to specialists. And, you will meet others with similar problems in your area, and how comforting is it to know that you are not alone??

Todd and I had about an hour and a half drive to get to Lansing and of course, we got up late...that is just us. But we got there in record time thanks to Todd's lead foot that he pulls out in times of emergency lol

When we got there, we had about 15 or so minutes to set up the table (APSFA was able to get a table...I think Lovenox was supposed to come and backed out...which was great for us to get out there like that!!) Then the seminar started.

First was an introduction from a Dr. John Penner who is a Professor for the MSU Department of Medicine as well as the Director of the Adult MSU Center for Bleeding and Clotting disorders. He also sees patients and I will be adding him to our dr list this weekend if he's not already there. He was very good from what I heard. He breifly explained clotting and introduced the seminar.

The next speaker was Dr. Roshni Kulkarni and she is the Director of the Division of Blood Disorders for the CDC as well as a Professor at the MSU Department of Pediatrics. Her part was titled "What are blood clots? Why and how do they form?" She had some excellent slides with animations on how the blood clots form and what happens with the different clotting disorders, such as APS and Factor V Leiden. Very interesting, and I learned alot from her presentation. She also said she worked for the Red Cross...not that that matters, but I wrote it down to tell Tina lol

Next up was Dr. Stephan Moll who is the Director of the University of North Carolina Thrombophilia Department as well as the Chair of the Medical and Scentific Advisory Board for NATT. He spoke twice, once before the break and once after. The first time he spoke it was supposed to be "Who is at risk for inherited and acquired clotting disorders" However it was really about Blood clots in general and how to prevent them and treatment. He was a very good speaker. Very personable and got the audience involved. He also added some humor in his slides, which was good because it was a long day.

Dr. Moll had added Todd into his "Lecture" as well. We had been in contact with him before hand and I sent him a picture as well as Todd full story...and I was impressed later on to find out that he actually read the whole thing because he spoke about a few different things that were on there (Todd's PFO, his TIA's, DVT, and Sticky Platelet Syndrome) He also mentioned APSFA a couple of times, and the FVL page a lot!! But he is the med advisory for the FVL page...so understandable.

I think Dr. Moll was the best speaker they had, hands down.

OK, then we had a Q&A time and a break. There were alot of interesting questions asked, none about APS specifically. and Dr. Moll answered most of them.

Next was a very inspirational personal story from a woman named Susan Mohr who is from Michigan, has FVL and had two DVT's...one in each arm. She ate right, was healthy, exercised, etc...and now she can barely do anything because of the risk of her forming another clot in her arms. She really broke down what it's like to have gone from a healthy indivudual to having a clot, and I plan on trying to get in touch with her and tell her that her speech really opened my eyes. They video taped the entire seminar and will eventually put it on a website...when they do, I will share it with you all, and her segment is a MUST see, esp for family members and caregivers. I had tears in my eyes. It was excellent.

The Role of Genetics was next. The speaker was Dr. Ajovi Scott-Emaukpor who is a Professor for the MSU Dept of Pediatrics as well and the Director of the Pediatric MSU Center for Bleeding and Clotting Disorders. His part mostly talked about the inherited clotting disorders, so it was mostly on Factor V Leiden. If Todd had FVL then I may have payed more attention, but the technical stuff really bored me...sorry to say. And he seemed to have not seen his slides prior to talking, he had to pause and read each one. I did notice that.

Dr. Moll's second lecture was next and he spoke about more treatment, who is at risk, and women's health issues. Again, it was mostly about FVL. But he did speak about some about nattokinase (which he does NOT approve of!!) and also the different birth control options and the risks.

Next was the most boring part of the lecture. Not because of the topic...it was running long, and it was lunch time and the woman had a delayed kind of speak that was just monotone and frankly hard to sit through. I am probably being too critical, but I was sitting there starving and was like, ok lady...speed it up. She was Dr. Renuka Gera, a professor for the MSU Department of Pediatrics and also the Associate Chair for Pediatrics. She spoke on Kids and Blood Clots. Some of it was interesting, and I will post another post with my notes in bullets and also some other things and pictures, but for the most part it was a snooze fest for me...but, I don't have kids and supposedly APS isn't "inherited".

Lunch was next and since Todd and I were basically "staff" we got to sit at the reserved table with the people who organized the event. They were both very nice, and we spoke about how we started the foundation and how todd was diagnosed and some other things about the seminar. About half way into our lunch, a woman from ProTime came to sit with us...very interesting talking to her. She basically said that the INR machines DO NOT work for APS patients, and that her company tells peple that and they choose to get them anyways and rish their lives...DUMB!!! Then she said she has family members calling her and saying, you knew this machine didn't work for this disease and you sold it to them anyway!! Well, the patient was well aware at the time of purchase, and in some cases the family members were calling because the family member had died. Scary stuff folks. Just say no to those machines! And this is straight from the representative's mouth!

After lunch we had some time to speak with some people who were visiting the tables. The only tables there were us, Probst compression stockings, Protime and there was NATT, Coumadin, Lovenox and ClotCare info all on one table. We gave out alot of brochures, booklets, newsletters and got a few people to sign up for our email list.

After the break was another Q&A session...more good questions, none APS related. Todd spoke up about people taking their medical information with them while traveling. They were really pushing for the patients to be pro-active in their care, and demand better care. If you don't feel they are doing enough, speak up!! Which is what the APSFA believes in as well!

The next speaker was Karen Boyd who helped to put the seminar on and she is from the MSU Center for Bleeding and Clotting Disorders. She is a social worker, and her speech was wonderful! All about patients and how they are treated, and how a good doctor who honestly takes the time to care and treat the patient makes all the difference. She was another one who when they put it online, it's a must see, IMO anyways. She had an Acronynm (?) for SPEAK UP and I am going to try to contact her to get what that was so I can post it. It was really good, but I didn't write it down.

The final speaker was Kathy Reed from NATT. She had a good talk about how she is a patient with FVL, and also a mother of a daughter with FVL. She also shared some inspirational quotes and spoke about NATT.

And then there were final Q&A and it was done. Afterwards, people were able to go up and have one on one time with the doctors and speakers. So while I packed up our table and spoke with the organizers a bit, Todd waited to talk to Dr. Moll and Kathy Reed.

And then we left...and headed for home!

It was a LONG day...but very very educational! I learned alot that I didn't know. And some stuff that I already did know, but that's ok too!

Ok, if you hung on this long, thanks...the next post will have bullets of my notes and pictures!



Here are my notes...
  • Thrombosis is the most major medical problem in the USA.
  • There are 1 million cases of DVT or PE per year in the USA.
  • Thrombosis occurs in 1-3 of ever 1000 people.
  • Factor V Leiden is the most common inherited blood disorder, 1/4 of all people who have had a blood clot carry the FVL gene.
  • Thrombophilia = Thrombo (to form a clot) & Philia (love/affection/obsession) So Thrombophilia is love to form a clot.
  • Sticky Platelet Syndrome was found in Michigan and most people dx with it are in MI or TX because the student or partner of the person who found it now lives in TX. lol
  • There are no clinical studies for SPS.
  • The woman from the CDC said that Senators listen to patients. and that we should contact our senators.
  • In children, 50% of all clotting disorders are genetic
  • APS is an aquired clotting disorder
  • Nattokinase has no clinical trials, is NOT FDA approved and do NOT count on it working.
  • There is a petition to the FDA to ban all 3rd generation (Yasmin, the patch) BC pills because of the clotting risks.
And that was all of my notes.

A few other things...Dr. Moll was great. he really impressed Todd and I, and we must have impressed him because he wants to work with us and the APSFA in a type of collaboration, which will REALLY help to increase our visibility and get us out there. He mentioned us when he was asking people to donate to NATT, which was good. He came up to us right away and shook our hands and said he was glad to meet us and that we should sit up close. Which was so he could point todd out to the audience as he talked about him lol. He also came and found us at lunch to get a picture with us for the NATT newsletter I assume. The picture is below as well as a picture of Todd and our table and Dr. Moll's slides with Todd on there! LOL

I will be adding the pictures to the website soon, they are pretty boring and just of the speakers.

Again, I cannot stress enough that if you are able to attend one of these seminars You should do so! And bring a family member along too!

Now for the pictures:





Sunday, March 25, 2007

WI, IL & IN Members: Improving Patient Quality of Life

Improving Patient Quality of Life
Saturday, May 5th, 2007 - Chicago, IL

Hosted by:

The National Alliance for Thrombosis and Thrombophilia (NATT), The International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP), and the Anticoagulation Forum

Location:

Chicago Marriott Downtown
Magnificant Mile
Chicago, IL
Ballroom III, 7th Floor
540 N. Michigan Ave.
Chicago, IL, 60611
http://marriott.com/hotels/travel/chidt-chicago-marriott-downtown-magnificent-mile

Agenda:

Click here to download the agenda http://www.nattinfo.org/acforumprogram.pdf.

Registration Information:

Elizabeth Varga
nattseminars@yahoo.com
614-355-3607

The APS Foundation of America, Inc is making arrangements to attend.

PA Members: Blood Clots & Clotting Disorders

Blood Clots and Blood Clotting Disorders:
Key Issues in Diagnosis, Treatment and Prevention
Saturday April 28, 2007

Hosted by:

The National Alliance for Thrombosis and Thrombophilia in conjunction with Western Pennsylvania Hospital / Western Pennsylvania Cancer Institute and University of Pittsburgh / Laboratory Institute for Transfusion Medicine

Location:

Sheraton Station Square Hotel
300 W. Station Square Drive
Pittsburgh, PA, 15219
412-261-2000

Agenda:

Click here to download the agenda: http://www.nattinfo.org/PittBloodClotSeminar.pdf.

Registration Information:

This seminar is FREE but registration before April 20th is requested.

Please complete the registration form and return immediately. You may also register by sending an email to: nattseminars@yahoo.com or by calling 412-578-4355.

The APS Foundation of America, Inc is making arrangements to attend.

PA Medical Professionals: Blood in Motion 2007

Blood in Motion 2007
Symposium on Thrombosis and Hemostasis featuring Women Issues
Friday April 27, 2007 - Saturday April 28, 2007

Hosted by:

The Western Pennsylvania Hospital and Western Pennsylvania Cancer Institute with University of Pittsburgh and Institute for Transfusion Medicine

Location:

Sheraton Station Square Hotel
300 W. Station Square Drive
Pittsburgh, PA, 15219
412-261-2000

Agenda:

This program is intended for Internal Medicine and Family Practice Physicians, Obstetricians and Gynecologists, Hematologists, medical and OB/GYN residents, physician assistants, nurses, medical students and anyone involved in the patient care, prevention, diagnosis and management of venous thromboembolic disease.

Click here to download the agenda: http://www.nattinfo.org/bloodinmotionprogram.pdf.

Registration Information:

Registration fee includes tuition, course syllabus, continental breakfast, breaks and luncheons. All cancellations must be received in writing. The registration fee, less $50.00 administrative fee, is refundable if your request is received by April 14, 2007.

Physician: $150.00
Allied Healthcare Professional, Others: $75.00
Fellows or Residents fee waived

Click here to download the agenda and registration form http://www.nattinfo.org/bloodinmotionprogram.pdf.

The APS Foundation of America, Inc is making arrangements to attend.

MN & WI Members: Blood Clots and Blood Clotting Disorders: An Education Seminar

Blood Clots and Blood Clotting Disorders:
An Education Seminar
Saturday April 21, 2007

Hosted by:
The National Alliance for Thrombosis and Thrombophilia (NATT) and the Hemophilia & Thrombosis Center, University of Minnesota Medical Center

Location:
Embassy Suites Hotel
2800 American Boulevard West
Bloomington, MN 55431
952-884-4811

Agenda:
Click here to download the agenda: http://www.nattinfo.org/UofMNThrombosisEducation.pdf.

Registration Information:

This seminar is FREE but registration before April 6, 2007 is required.

Please call Fairview On-Call at 612-672-7272 to register.

The APS Foundation of America, Inc is making arrangements to attend.

Monday, January 29, 2007

What is “Micro-Clotting”?

What is “Micro-Clotting”?

By: Thomas L. Ortel, MD, PhD
Simply put, micro-clotting, better referred to as “microvascular thrombosis”’ describes blood clotting that is occurring in some of the smallest blood vessels in the body.

http://www.apsfa.org/docs/APSFAVol4Winter2007.pdf

Friday, January 26, 2007

PhoneRaiser - Fundraiser

We have started a new fund raiser for 2007. We are collecting used cell phones. The average American family has 3 old cell phones in their home. This is another easy way to donate to and support the APSFA without making a monetary donation. You can send us your used phones, or set up a collection box in your area.
Click HERE for more information.

Sunday, November 26, 2006

APSFA Exclusive Holiday Ornament

We are offering this exclusive holiday ornament on our CafePress site. The ornament will feature a different snowflake every year, so this is truly a collector's item. The ornaments are $8.00 and $2.00 from each purchase goes to the APSFA. This design is only available until Dec 31, so you'll need to act fast!

http://www.cafepress.com/apsfoundation/1952386

Sunday, November 05, 2006

2006 Holiday Giving Tree!



The holiday Giving Tree at the APS Foundation of America, Inc holds a special meaning for the members of the APSFA and the community it serves.

Each ornament and present signifies a donation made to the APSFA in the name of an individual or group honored at this special time of the year.

This donation will enable us to keep our unique non-profit organization operating and help promote awareness of Antiphospholipid Antibody Syndrome.

http://www.apsfa.org/givingtree.htm

Friday, October 27, 2006

APSFA in Stroke Connections!

We made it into the American Stroke Association's Stroke Connection Magazine. The November/December 2006.

I call that a nice sized ad! :)





Friday, October 20, 2006

Roche Diagnostics Announces Nationwide Recall on Medical Device Used to Determine Blood Clotting Time

Roche Diagnostics Announces Nationwide Recall on Medical Device Used to Determine Blood Clotting Time

Contact:
Roche Diagnostics' Point-of-Care Technical Service Center 1-800-820-0995

FOR IMMEDIATE RELEASE -- October 19, 2006 -- Roche Diagnostics is notifying users of an important recall of all CoaguChek PT test strips currently in the market, due to a potential for a test strip defect that may cause falsely elevated test results. The company has identified the root cause and is instituting corrective action with highest priority. To date, the company has confirmed one incident and its internal investigation suggests that a small percentage of strips may be affected. To date, no deaths, illnesses or injuries have been reported due to this issue.

CoaguChek PT test strips are used by patients in the home and by professionals in medical settings to determine blood clotting time of patients taking anti-coagulants, also known as blood thinners. Blood thinners are used to treat patients with a potential for blood clots, for example, patients with heart valve replacements, certain types of heart disease or blood clots in their legs. Incorrect results may have serious or life threatening consequences because patients may be improperly treated.

Roche Diagnostics has determined the potential for a test strip defect when insufficient active ingredient (thromboplastin) is applied to the test strip, possibly causing falsely elevated results. As a result of the unpredictable positive bias, patient test results may be falsely elevated. This can result in an incorrect dose of anti-coagulant or unnecessary corrective measures to reduce the effect of circulating anti-coagulants. Both incorrect treatment choices could put patients at risk for blood clots.

Roche Diagnostics is notifying all home users of the CoaguChek PT test strip to immediately discontinue use of and discard the product as well as to consult with their health care provider to determine alternate testing methodologies and clinical implications. U.S. customers with questions or concerns should call Roche Diagnostics' Point-of-Care Technical Service at 1-800-820-0995.

Roche Diagnostics is notifying all health care professionals who use the CoaguChek PT test strip to institute 'duplicate testing' - or two strips on each patient - using different lot numbers to reduce the risk of bias. If health care professionals require another lot to enable duplicate testing, they are encouraged to call their medical supply distributor. For general questions, health care professionals should call the company's Point-of-Care Technical Service Center at 1-800-820-0995. These actions must remain in place until the issue has been resolved and health care professionals are supplied with unaffected replacement product.

Letters are being sent to customers, providers and physicians - including additional information regarding this voluntary action. Roche Diagnostics is working with its affiliates worldwide to coordinate appropriate activities. Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA's MedWatch Adverse Event Reporting program online http://www.fda.gov/medwatch/report.htm by phone 1-800-FDA-1088, or by returning the postage-paid FDA form 3500 [which may be downloaded from http://www.fda.gov/medwatch/getforms.htm by mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 or fax 1-800-FDA-0178. This action is being taken by Roche Diagnostics with the knowledge of the U.S. Food and Drug Administration.

http://www.fda.gov/Medwatch/safety/2006/safety06.htm#CoaguChek

http://www.fda.gov/oc/po/firmrecalls/roche10_06.html

Home INR Machines and Antiphospholipid Antibodies

Finally - someone has spoken up and said these machines do not work with us patients....that you are really playing Russian Roulette!

http://www.fvleiden.org/ask/94.html

Q."I bought a home Coaguchek® INR machine. My insurance company refused to pay for it, so I paid for it out of my own money, close to $ 2000. I have antiphospholipid antibodies and am on warfarin. Initially, I did many comparisons between the machine and hospital-testing INRs, before I and my doctor accepted the machine's numbers. Things were initially working fine. But recently I noticed that there was a discrepancy between my home INR machine (which read an INR of 7.8) and a hospital INR (which was 3.5). I ran all the controls for the machine (liquid and electronic) and they all ran fine. I called the company. They said their machine was fine. I bought a new box of test strips and the discrepancies were still there. I am done using the machine. I will deal with the hassle of going to the lab. At least I know those INR's are correct. I am really disgusted at what a waste of money the machine was."

A. Home INR machines do not give accurate readings in about 1/3 rd of patients with antiphospholipid antibodies who are on warfarin. This is not due to the machine malfunctioning, but likely due to antibodies interfering with the test method of the home INR machines

In one third of patients with antiphospholipid antibodies the INRs read by the home INR machines are unreliable: (a) they either read too high, compared to INRs tested in a laboratory from an i.v. stick (reference 2), or (b) the instruments flash up an error message (reference 1). This inaccuracy is likely caused by the presence of the antiphospholipid antibodies. Since antibody levels can fluctuate over time, the instrument may give accurate readings at times when the antibody levels are low, but inaccurate ones at times when the levels are higher. This is a phenomenon not unique to the Coaguchek® instrument, but is also seen with the ProTime® and the INRatio® instruments (reference 1,2). In patients who do not have antiphospholipid antibodies the home INR machines give reliable readings and are a good way to monitor warfarin therapy (ref. 3).

Personal Comment:
Because of the potential inaccuracies of home INR machines in patients with antiphospholipid antibodies, I prefer to see these patients not use home INR machines, but have their warfarin monitored with i.v. blood draws through an office or hospital laboratory. However, if a patient with antiphospholipid antibodies decides to use a home INR machine, I recommend that initially and every so often thereafter, such as every 6 months, the INR of the machine be compared to the INR obtained at a laboratory. If the machine gives unreliable readings, the patient should switch to i.v. stick INR measurements through a laboratory. Alternatively, the patient could correlate the INRs obtained with the home INR machine to the laboratory INR, and thus determine his/her unique therapeutic range with the machine. The patient could then continue using the machine.

References:

Perry SL, Samsa GP, Ortel TL: Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. Thromb Haemost 2005 Dec;94(6):1196-202.
Moll S, Wobbleton DL, Misita CP, Bryant B, Malone R, Musty M: INR Determination by plasma-based methods versus point-of-care instruments in patients with antiphospholipid antibody syndrome on anticoagulants. Int Soc Thromb Haemost meeting; Sydney, Australia, Aug 2005. J Thromb Haemost. 2005 Aug;3(suppl 1);abstract.
Yang DT, Robetorye RS, Rodgers GM: Home prothrombin time monitoring: a literature analysis. Am J Hematol 2004;77:177-186.

Friday, August 18, 2006

Shopping for the APS Foundation of America, Inc.

http://www.apsfa.org/shopping.htm

We've discovered a great way to raise money for the APS Foundation of America, Inc. and it doesn't cost me any extra time or money.

All you do is start your online shopping at www.apsfa.org/shopping.htm and buy the gifts and things you need everyday at brand name retailers -- including Amazon.com, Dell, J.Crew, Martha Stewart, Gap, L.L. Bean, 1-800-FLOWERS.com, OfficeMax.com and more than 350 others. Just be sure to designate the APS Foundation of America, Inc. as your charity.

At no extra cost to you, up to 35% of every purchase you make automatically goes to the APS Foundation of America, Inc.!

So remember, if you're going to buy online, BuyFor Charity at: http://www.buyforcharity.com.

One more thing! Help others make a difference by sending this email to friends and family who are ready to make a change and support the APS Foundation of America, Inc. Just think... if everyone who shops online remembered to shop through BuyForCharity.com, what a huge difference we'd make for the all the charitable organizations that make our world a better place!

Do You Use a Home INR Machine??? We need your story!!

Do You Use a Home INR Machine??? We need your story!!

The APS Foundation of America, Inc. planning a "testimonial" page for people to turn to when deciding whether or not to buy/use the home INR machines (ex, Coagucheck, HemoSense, etc).

We're looking for positive and negative stories of the machine(s) that you have used. Please include your diagnosis and cost of the machine when all was said and done. We would like to use your first name and last initial and your State or Country.

Please email us at apsfa@apsfa.org for more information!

Monday, August 07, 2006

Need Flowers?

The APS Foundation of America, Inc. has partnered with flowerpetal.com to provide you a state-of-the-art shopping experience and unparalleled service for purchasing flowers and gifts online.

How does it work? flowerpetal.com, a Las Vegas-based e-commerce provider servicing the flower and gift industry, handles order processing, fulfillment and customer service, all backed by their 100% Satisfaction Guarantee. 12% of your purchases on this site (excluding tax) benefit our organization and its cause. You may also make an optional donation at the end of the purchase process.

Thursday, August 03, 2006

SERONEGATIVE ANTIPHOSPHOLIPID ANTIBODY SYNDROME (SNAPS)…AND SNAPPING TO IT!!

By: Gale McCarty, MD, FACR, FACP “You don’t have the syndrome because your tests are low level or negative…” or “You have livedo, a heart valve problem, and thrombocytopenia, but these aren’t listed as criteria for diagnosis” are comments made frequently by healthcare providers from many specialties to patients with clinical features suggesting the Antiphospholipid Antibody Syndrome (APS).

http://www.apsfa.org/docs/APSFAVol2Summer2006.pdf

Saturday, July 08, 2006

GoodSearch.com Fundraiser

What if APS Foundation of America - APSFA earned a penny every time you searched the Internet? Well, now we can!

GoodSearch.com is a new search engine that donates half its revenue, about a penny per search, to the charities its users designate. You use it just as you would any search engine, and it’s powered by Yahoo!, so you get great results. Just go to http://www.goodsearch.com/ and be sure to enter APS Foundation of America - APSFA as the charity you want to support. Just 500 of us searching four times a day will raise about $7300 in a year without anyone spending a dime! And, be sure to spread the word!

Monday, May 08, 2006

NIH Launches Clinical Studies Nationwide to Investigate Rare Diseases


FOR IMMEDIATE RELEASE

Friday, May 5, 2006
CONTACT:
Joyce McDonald orAnn Puderbaugh
301-435-0888

NIH Launches Clinical Studies Nationwide to Investigate Rare Diseases $71 Million Effort to Address Neglected ConditionsThe National Institutes of Health (NIH) announced today it is launching the first clinical studies of its Rare Diseases Clinical Research Network (RDCRN). More than 20 studies are expected to open in the next few months at about 50 sites across the United States and in several other countries including the United Kingdom, Japan, and Brazil.

Rare Diseases Studies Listed By City:http://www.ncrr.nih.gov/clinical/rdcrn_studylist.asp

Officially, a rare disease is defined as a disease or condition affecting fewer than 200,000 persons in the United States. About 6,000 such disorders have been identified, impacting an estimated 25 million Americans. Few drug companies conduct research into rare diseases since there is little chance to recoup the costs of developing treatments for such small, geographically dispersed populations.

“By studying the genetic component of these rare diseases, we hope to be able to better predict the course of the illnesses and provide more effective, personalized treatments for those afflicted,” said Elias A. Zerhouni, M.D., NIH Director. “Ultimately, this individualized approach, completely different from how we treat patients today, will allow us to prevent or to promptly treat the complications arising from these genetic disorders.”

The RDCRN has received five-year funding awards totaling $71 million and is coordinated primarily by two NIH components — the Office of Rare Diseases (ORD) and the National Center for Research Resources (NCRR). A central data and technology coordinating center and 10 research consortia will investigate a variety of diseases including Angelman, Rett, Prader-Willi syndromes; myelodysplastic syndrome and other bone marrow failure conditions; lymphangioleiomyomatosis (LAM), rare genetic disorders of the airways, and other rare lung diseases; episodic ataxia, Andersen-Tawil syndrome, and nondystrophic myotonias; several vasculitides; urea cycle disorders; antiphospholipid syndrome and other rare thrombotic diseases; rare pediatric liver diseases; and rare genetic steroid defects.

"Increased collaboration among researchers investigating rare diseases will not only lead to discoveries that will help prevent and treat these conditions, but may also produce medical advances that will benefit the population in general,” said Stephen Groft, Pharm.D., Director of NIH's Office of Rare Diseases.

The initiative includes interventional trials to test new therapies or drugs, as well as longitudinal or natural history studies that will provide information about the characteristics of rare diseases and their progression over time. Data collection standards have been established for the research projects and the data produced will be made publicly available with appropriate safeguards for patient confidentiality.

“This network was created to share the experience, approaches, and tools for the study of rare diseases and to train the next generation of investigators,” said Barbara M. Alving, M.D., NCRR’s Acting Director. “The adoption of standards and common data elements across diseases is groundbreaking, promotes cross-disease analysis, and provides a rich source of information to be mined by researchers around the world.”

Each consortium in the network includes active participation by the relevant patient advocacy groups. In addition, the Coalition of Patient Advocacy Groups (CPAG) was created to represent the more than 30 patient advocacy groups involved in the network. CPAG has been instrumental in outreach to the affected populations and gaining their input into the development of studies.

“In forming this coalition of rare disease groups, NIH has created a powerful vehicle for us to collaborate and communicate with one another that has already brought dividends,” said Patrick Cochran, CPAG Chair and founder of the Periodic Paralysis Association. “Not only have we been able to share information and learn from each other, by working together we have also secured additional support from foundations and corporations.”

The RDCRN is funded by the ORD; NCRR; National Heart, Lung and Blood Institute; National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; National Institute of Arthritis and Musculoskeletal and Skin Diseases; and National Institute of Diabetes and Digestive and Kidney Diseases — all components of NIH — an agency of the Department of Health and Human Services. For more information about the RDCRN, please visit: http://www.ncrr.nih.gov/clinical/cr_rdcrn.asp.

NCRR provides laboratory scientists and clinical researchers with the environments and tools they need to understand, detect, treat, and prevent a wide range of diseases. This support enables discoveries that begin at a molecular and cellular level, move to animal-based studies, and then are translated to patient-oriented clinical research, resulting in cures and treatments for both common and rare diseases. NCRR connects researchers with one another and with patients and communities across the nation to harness the power of shared resources and research. For more information, visit http://www.ncrr.nih.gov.

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

http://www.nih.gov/news/pr/may2006/ncrr-05.htm

The APS Foundation of America, Inc does work closely with the Rare Thrombotic Diseases Consortium which works with the Rare Diseases Clinical Research
Network.

http://rarediseasesnetwork.epi.usf.edu/
http://rarediseasesnetwork.epi.usf.edu/rtdc/learnmore/index.htm#aps
http://rarediseasesnetwork.epi.usf.edu/rtdc/takeaction/groups.htm

We will posting more information as it arrives on progress they are making and when the contact registry is ready to be launched.